DNDi - NewsLetter


HOME
ABOUT DNDi ABOUT THIS SPECIAL ISSUE EDITORIAL: "From Pipeline to the Patients: a Changing Landscape for VL" CALENDAR HOW CAN YOU HELP DNDi?
Developping New Health Tools for VL Patients The Fever of the Poor VL Combination Therapy in Asia VL Cinical Studies in East Africa Prospects of Engaging VL Clinical Research for Latin America Seven-Year-Old Saisuru from Uganda: One Case among Many LEAP: A Step Together in the Right Direction Visceral Leishmaniasis (VL) Challenges to Finding Drug Candidates that can enter Clinical Development Promising Results from the VL Lead Optimisation Consortium with Advinus Balanced Funding Supports DNDi'S VL Portfolio There can be no Health Benefit without Access to Treatments Recent VL Scientific Publications NECT, a New Combination Therapy against Sleeping Sickness Will Now be Available Els, a Mover and Shaker, from Concept to Care! NEW Addresses of Regional Offices in Rio, USA and Japan WorldLeish4: DNDi Sponsors Two Symposia on the Path to Delivering Better Treatments for VL News from Donors Contact DNDi

NEW Addresses of Regional Offices
in Rio, USA and Japan

DNDi Latin America
the Latin America team has just moved to a new office at Jardim Botânico Rua Santa Heloisa 5 - Jardim Botânico
Rio de Janeiro, RJ 22460-080
Brazil
Tel: + 55 21 3114-4937 or + 55 21 2274-4685
www.dndi.org.br

DNDi North America
has moved to
40 Wall Street, 24th Floor
New York, NY, 10005
phone (646) 616-8680
www.dndina.org

DNDi Japan Office
3-1-4 Nishi-Shinjuku
Shinjuku-ku, Tokyo 160-0023
Japan
Tel: +81 3 6304 5588
www.dndijapan.org

Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.dndi.org